This clinical trial studies whether a new supportive care program may help to improve the quality of life for cancer patients after treatment is over. Educational sessions include information about managing expectations about life after cancer treatment, enhancing self-management of residual symptoms, strengthening social support, and managing uncertainty, which may help to reduce the symptom burden after lung cancer treatment.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05087251.
PRIMARY OBJECTIVES:
I. Test the efficacy of the Transitions Program in improving patient-reported quality of life relative to the control group.
II. Test the efficacy of the Transitions Program in improving intervention targets (future uncertainty, symptom burden, and social support) relative to the control group.
III. Explore the extent to which the effects of the Transitions Program on quality of life and intervention targets vary by clinical factors.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM 1: Starting 6 weeks after standard of care cancer treatment is complete, patients receive up to 5 weekly psycho-educational study sessions over 50 minutes each.
ARM 2: Starting 6 weeks after standard of care cancer treatment is complete, patients receive a psycho-educational study session over 50 minutes.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationDana-Farber Harvard Cancer Center
Principal InvestigatorLara Traeger
